Literature DB >> 22048285

Role of gabapentin in preventing fentanyl- and morphine-withdrawal-induced hyperalgesia in rats.

Xin Wei1, Wei Wei.   

Abstract

PURPOSE: This study was undertaken to examine the effect of gabapentin for preventing hyperalgesia induced by morphine and fentanyl withdrawal in rats.
METHODS: To induce hyperalgesia, Sprague Dawley (SD) rats were subcutaneously injected with fentanyl four times at 15-min intervals (60 μg/kg per injection), resulting in total dose of 240 μg/kg over 1 h, and morphine 10 mg/kg twice daily for 7 days. The effect of gabapentin was detected with behavioral tail-flick and paw-withdrawal tests.
RESULTS: Drug termination produced significant decrease in antinociception thresholds (P < 0.05 vs. saline group), indicating that the rats became sensitive to thermal stimuli. In rats that received combined treatment with fentanyl/morphine and gabapentin (25/50 mg/kg), results demonstrated that there were no significant decreases in antinociception thresholds (vs. saline group) after opioid withdrawal. Gabapentin (50 mg/kg) could also prevent morphine tolerance. The 50% effective dose (ED50) value was 12.5 mg/kg in tail-flick and 13.6 mg/kg in paw-withdrawal tests.
CONCLUSIONS: The study showed that gabapentin can significantly prevented opioid-induced hyperalgesia (OIH) induced caused by fentanyl and morphine, suggesting a role for the addition of gabapentin in the perioperative period and during chronic pain treatment as an effective drug to prevent OIH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048285     DOI: 10.1007/s00540-011-1272-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  36 in total

1.  Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats.

Authors:  C S Wong; M M Hsu; R Chou; Y Y Chou; C S Tung
Journal:  Br J Anaesth       Date:  2000-11       Impact factor: 9.166

2.  Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats.

Authors:  Vasudeva Raghavendra; Flobert Y Tanga; Joyce A DeLeo
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

3.  Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain.

Authors:  M J Field; E F Holloman; S McCleary; J Hughes; L Singh
Journal:  J Pharmacol Exp Ther       Date:  1997-09       Impact factor: 4.030

4.  The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine.

Authors:  L Singh; M J Field; P Ferris; J C Hunter; R J Oles; R G Williams; G N Woodruff
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

5.  Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.

Authors:  Frederik Rode; Tine Broløs; Gordon Blackburn-Munro; Ole J Bjerrum
Journal:  Psychopharmacology (Berl)       Date:  2006-06-17       Impact factor: 4.530

Review 6.  The mechanism of action of gabapentin in neuropathic pain.

Authors:  J Kenneth Baillie; Ian Power
Journal:  Curr Opin Investig Drugs       Date:  2006-01

7.  A combination of gabapentin and morphine mediates enhanced inhibitory effects on dorsal horn neuronal responses in a rat model of neuropathy.

Authors:  Elizabeth A Matthews; Anthony H Dickenson
Journal:  Anesthesiology       Date:  2002-03       Impact factor: 7.892

8.  Gabapentin enhances the analgesic effect of morphine in healthy volunteers.

Authors:  K Eckhardt; S Ammon; U Hofmann; A Riebe; N Gugeler; G Mikus
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

9.  The effects of intrathecal gabapentin on spinal morphine tolerance in the rat tail-flick and paw pressure tests.

Authors:  C Hansen; I Gilron; M Hong
Journal:  Anesth Analg       Date:  2004-10       Impact factor: 5.108

10.  Fentanyl-induced neurotoxicity and paradoxic pain.

Authors:  Tomasz R Okon; Mathews Lal George
Journal:  J Pain Symptom Manage       Date:  2008-01-28       Impact factor: 3.612

View more
  5 in total

1.  Differential tolerance to morphine antinociception in assays of pain-stimulated vs. pain-depressed behavior in rats.

Authors:  Ahmad A Altarifi; S Stevens Negus
Journal:  Eur J Pharmacol       Date:  2014-12-18       Impact factor: 4.432

2.  Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial.

Authors:  Jennifer Hah; Sean C Mackey; Peter Schmidt; Rebecca McCue; Keith Humphreys; Jodie Trafton; Bradley Efron; Debra Clay; Yasamin Sharifzadeh; Gabriela Ruchelli; Stuart Goodman; James Huddleston; William J Maloney; Frederick M Dirbas; Joseph Shrager; John G Costouros; Catherine Curtin; Ian Carroll
Journal:  JAMA Surg       Date:  2018-04-01       Impact factor: 16.681

3.  Gabapentin Effect on Pain Associated with Heroin Withdrawal in Iranian Crack: a Randomized Double-blind Clinical Trial.

Authors:  Behnaz Behnam; Vahid Semnani; Nadia Saghafi; Raheb Ghorbani; Mina Dianak Shori; Samaneh Ghooshchian Choobmasjedi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 4.  Targeting Cytokines for Morphine Tolerance: A Narrative Review.

Authors:  Dai-Qiang Liu; Ya-Qun Zhou; Feng Gao
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

5.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.